← Leaderboards
William E. Harmon
Children'S Hospital Boston
$17,038,662
Attributed
$17,038,662
Total exposure
15
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.9M · FY2005–12$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$18,844,706 · 16
By mechanism
U01$16,322,827 · 4
T32$2,031,569 · 1
M01$490,310 · 11
Top collaborators
No co-investigators on record.
Most similar at Children'S Hospital Boston
Same institution · by research overlap
- Pamela Ann Kozlowski$5,305,760
Others in their field
Top investigators on “Kidney Transplantation”
- Peter Scott Heeger · Case Western Reserve University$86,758,000
- Joren C Madsen · Massachusetts General Hospital$51,129,981
- Dorry Segev · Johns Hopkins University$40,143,271
- Peter G Stock · University Of California San Francisco$37,405,503
- Robert M Merion · University Of Michigan At Ann Arbor$29,566,275
- John C Magee · University Of Michigan At Ann Arbor$28,786,531
Research focus
Kidney TransplantationClinical ResearchHuman SubjectPediatricsTransplant RejectionHuman Therapy EvaluationChildhoodArtificial ImmunosuppressionClinical TrialsTransplantationCooperative StudyProtocols DocumentationCalcineurin InhibitorNatural ImmunosuppressionT-LymphocytePreventChronicImmune Tolerance /UnresponsivenessLeadSirolimusFunctional DisorderAdultAllograftingAlloantigen
Grant awards (44)
Novel Therapies for Chronic Renal Allograft Dysfunction in Children$780,422
U01 · FY2012 · AI · contact PI
Novel Therapies for Chronic Renal Allograft Dysfunction in Children$827,146
U01 · FY2011 · AI · contact PI
Novel Therapies for Chronic Renal Allograft Dysfunction in Children$904,595
U01 · FY2010 · AI · contact PI
Novel Therapies for Chronic Renal Allograft Dysfunction in Children$809,785
U01 · FY2009 · AI · contact PI
Novel Therapies for Chronic Renal Allograft Dysfunction in Children$1,479,847
U01 · FY2008 · AI · contact PI
Research Training in Pediatric Nephrology$219,125
T32 · FY2008 · DK · contact PI
B7 Costimulatory Blockade in Pediatric Transplantation$1,400,848
U01 · FY2007 · AI · contact PI
Research Training in Pediatric Nephrology$232,252
T32 · FY2007 · DK · contact PI
STUDY OF CAMPATH-1H COMBINED WITH MMF AND SIROLIMUS (PC01)$230,191
M01 · FY2007 · RR · contact PI
Research Training in Pediatric Nephrology$56,339
T32 · FY2007 · DK · contact PI
RANDOMIZED, MULTICENTER TACROLIMUS WITH STEROID VS STEROID FREE (SNS-01)$23,879
M01 · FY2007 · RR · contact PI
CALCINEURIN INHIBITOR SPARING IN KIDNEY TRANSPLANTATION (CN-01)$1,447
M01 · FY2007 · RR · contact PI
B7 Costimulatory Blockade in Pediatric Transplantation$1,407,620
U01 · FY2006 · AI · contact PI
Research Training in Pediatric Nephrology$221,835
T32 · FY2006 · DK · contact PI
Research Training in Pediatric Nephrology$54,240
T32 · FY2006 · DK · contact PI
PHASE II OF CAMPATH-1H COMBINED WITH MMF AND SIROLIMUS (PC01)$36,184
M01 · FY2006 · RR · contact PI
RANDOMIZED, MULTICENTER TACROLIMUS WITH STEROID VS STEROID FREE (SNS-01)$19,939
M01 · FY2006 · RR · contact PI
CALCINEURIN INHIBITOR SPARING PROTOCOL IN PEDIATRIC KIDNEY TRANSPLANTATION (CN-$1,478
M01 · FY2006 · RR · contact PI
B7 Costimulatory Blockade in Pediatric Transplantation$1,406,612
U01 · FY2005 · AI
Research Training in Pediatric Nephrology$209,607
T32 · FY2005 · DK
PHASE II OF CAMPATH-1H COMBINED WITH MMF AND SIROLIMUS (PC01)$14,526
M01 · FY2005 · RR
CALCINEURIN INHIBITOR SPARING PROTOCOL IN PEDIATRIC KIDNEY TRANSPLANTATION$12,347
M01 · FY2005 · RR
STEROID W/DRAWAL IN SIROLIMUS &CYCLOSPORINE TX IN TRANSPLANT PT$7,262
M01 · FY2005 · RR
USE OF RITUXAN IN PEDSSOLID ORGAN RECIPW/POST-TRANSPL LYMPHOPROLIFERATIVE DS$2,179
M01 · FY2005 · RR
B7 Costimulatory Blockade in Pediatric Transplantation$1,372,176
U01 · FY2004 · AI
Research Training in Pediatric Nephrology$229,661
T32 · FY2004 · DK
Calcineurin inhibitor sparing protocol in pediatric kidney transplantation$22,527
M01 · FY2004 · RR
Steroid Withdrawal in Sirolimus and Cyclosporine Treated Transplant Recipients$3,165
M01 · FY2004 · RR
Use of Rituxan in Peds.Solid Organ Recip.W/Post-Transpl. Lymphoproliferative Ds.$186
M01 · FY2004 · RR
B7 Costimulatory Blockade in Pediatric Transplantation$784,928
U01 · FY2003 · AI
RESEARCH TRAINING IN PEDIATRIC NEPHROLOGY$225,997
T32 · FY2003 · DK
CD40L BLOCKADE IN PEDIATRIC RENAL TRANSPLANTATION$1,142,480
U01 · FY2002 · AI
NAPRTCS CLINICAL TRIALS IN PRIMARY &REPEAT TRANSPLANTS$642,000
U01 · FY2002 · AI
RESEARCH TRAINING IN PEDIATRIC NEPHROLOGY$206,267
T32 · FY2002 · DK
NAPRTCS CLINICAL TRIALS IN PRIMARY &REPEAT TRANSPLANTS$43,011
U01 · FY2002 · AI
CONTROLLED TRIAL OF INDUCTION THERAPY$28,750
M01 · FY2002 · RR
NAPRTCS CLINICAL TRIALS IN PRIMARY &REPEAT TRANSPLANTS$1,121,033
U01 · FY2001 · AI
CD40L BLOCKADE IN PEDIATRIC RENAL TRANSPLANTATION$1,114,531
U01 · FY2001 · AI
RESEARCH TRAINING IN PEDIATRIC NEPHROLOGY$196,141
T32 · FY2001 · DK
CONTROLLED TRIAL OF INDUCTION THERAPY$28,750
M01 · FY2001 · RR
CONTROLLED TRIAL OF INDUCTION THERAPY$28,750
M01 · FY2001 · RR
CD40L BLOCKADE IN PEDIATRIC RENAL TRANSPLANTATION$1,085,793
U01 · FY2000 · AI
RESEARCH TRAINING IN PEDIATRIC NEPHROLOGY$180,105
T32 · FY2000 · DK
CONTROLLED TRIAL OF INDUCTION THERAPY$28,750
M01 · FY2000 · RR